170 related articles for article (PubMed ID: 8626365)
1. Therapeutic dose range of nefazodone in the treatment of major depression.
Robinson DS; Marcus RN; Archibald DG; Hardy SA
J Clin Psychiatry; 1996; 57 Suppl 2():6-9. PubMed ID: 8626365
[TBL] [Abstract][Full Text] [Related]
2. Responders to antidepressant drug treatment: a study comparing nefazodone, imipramine, and placebo in patients with major depression.
Cohn CK; Robinson DS; Roberts DL; Schwiderski UE; O'Brien K; Ieni JR
J Clin Psychiatry; 1996; 57 Suppl 2():15-8. PubMed ID: 8626358
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, placebo-controlled trial of two dose ranges of nefazodone in the treatment of depressed outpatients.
Mendels J; Reimherr F; Marcus RN; Roberts DL; Francis RJ; Anton SF
J Clin Psychiatry; 1995; 56 Suppl 6():30-6. PubMed ID: 7649971
[TBL] [Abstract][Full Text] [Related]
4. Tolerability and safety: essentials in antidepressant pharmacotherapy.
Lader MH
J Clin Psychiatry; 1996; 57 Suppl 2():39-44. PubMed ID: 8626362
[TBL] [Abstract][Full Text] [Related]
5. Nefazodone: aspects of efficacy.
Rickels K; Robinson DS; Schweizer E; Marcus RN; Roberts DL
J Clin Psychiatry; 1995; 56 Suppl 6():43-6. PubMed ID: 7649973
[TBL] [Abstract][Full Text] [Related]
6. The safety profile of nefazodone.
Robinson DS; Roberts DL; Smith JM; Stringfellow JC; Kaplita SB; Seminara JA; Marcus RN
J Clin Psychiatry; 1996; 57 Suppl 2():31-8. PubMed ID: 8626361
[TBL] [Abstract][Full Text] [Related]
7. Fast onset: an open study of the treatment of major depressive disorder with nefazodone and pindolol combination therapy.
Bakish D; Hooper CL; Thornton MD; Wiens A; Miller CA; Thibaudeau CA
Int Clin Psychopharmacol; 1997 Mar; 12(2):91-7. PubMed ID: 9219044
[TBL] [Abstract][Full Text] [Related]
8. Efficacy in long-term treatment of depression.
Montgomery SA
J Clin Psychiatry; 1996; 57 Suppl 2():24-30. PubMed ID: 8626360
[TBL] [Abstract][Full Text] [Related]
9. The effect of nefazodone on comorbid anxiety symptoms associated with depression: experience in family practice and psychiatric outpatient settings.
Zajecka JM
J Clin Psychiatry; 1996; 57 Suppl 2():10-4. PubMed ID: 8626357
[TBL] [Abstract][Full Text] [Related]
10. Antidepressant dosing and switching guidelines: focus on nefazodone.
Zajecka J; McEnany GW; Lusk KM
J Clin Psychiatry; 2002; 63 Suppl 1():42-7. PubMed ID: 11890564
[TBL] [Abstract][Full Text] [Related]
11. Nefazodone: single versus twice daily dose.
Voris JC; Shaurette GN; Sebastian PS; Will-Wallace LA
Pharmacotherapy; 1998; 18(2):379-80. PubMed ID: 9545158
[TBL] [Abstract][Full Text] [Related]
12. Nefazodone in the treatment of premenstrual syndrome: a preliminary study.
Freeman EW; Rickels K; Sondheimer SJ; Denis A; Pfeifer S; Weil S
J Clin Psychopharmacol; 1994 Jun; 14(3):180-6. PubMed ID: 8027414
[TBL] [Abstract][Full Text] [Related]
13. An open-label trial of nefazodone in high comorbidity panic disorder.
DeMartinis NA; Schweizer E; Rickels K
J Clin Psychiatry; 1996 Jun; 57(6):245-8. PubMed ID: 8666561
[TBL] [Abstract][Full Text] [Related]
14. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
15. Redistribution of slow wave activity of sleep during pharmacological treatment of depression with paroxetine but not with nefazodone.
Argyropoulos SV; Hicks JA; Nash JR; Bell CJ; Rich AS; Nutt DJ; Wilson S
J Sleep Res; 2009 Sep; 18(3):342-8. PubMed ID: 19549078
[TBL] [Abstract][Full Text] [Related]
16. Placebo-controlled dose-ranging trial designs in phase II development of nefazodone.
D'Amico MF; Roberts DL; Robinson DS; Schwiderski UE; Copp J
Psychopharmacol Bull; 1990; 26(1):147-50. PubMed ID: 2196622
[TBL] [Abstract][Full Text] [Related]
17. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP
Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641
[TBL] [Abstract][Full Text] [Related]
18. Redefining antidepressant efficacy toward long-term recovery.
Thase ME
J Clin Psychiatry; 1999; 60 Suppl 6():15-9. PubMed ID: 10235120
[TBL] [Abstract][Full Text] [Related]
19. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
20. Nefazodone treatment of cocaine dependence with comorbid depressive symptoms.
Ciraulo DA; Knapp C; Rotrosen J; Sarid-Segal O; Ciraulo AM; LoCastro J; Greenblatt DJ; Leiderman D
Addiction; 2005 Mar; 100 Suppl 1():23-31. PubMed ID: 15730347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]